All In Biotech

Free tool

FAERS Monitor: Airduo Digihaler

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208799 or its brand name (Airduo Digihaler, Fluticasone Propionate, Salmeterol Xinafoate). Reports on generic versions are filed under their own applications.

Reports

2,689

Serious

335

12% of reports

Hospitalization

156

Death reported

33

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • product dose omission issue1,561
  • off label use280
  • product use issue263
  • drug ineffective243
  • dyspnoea198
  • cough98
  • wrong technique in product usage process95
  • accidental underdose85
  • asthma85
  • product use in unapproved indication63
  • dysphonia53
  • headache45
  • incorrect dose administered41
  • pain38
  • wheezing38

Reports by year received

View as table
YearReports
20081
20092
20101
20121
20141
201711
201854
201950
202050
2021135
2022233
2023281
2024729
2025383
2026757

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,470 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
accidental underdoseSignal8546.537.73,716
product dose omission issueSignal1,56141.740.462,572
product use issueSignal26311.09.82,388
dysphoniaSignal537.15.4272
asthmaSignal855.94.8342
wheezingSignal385.03.7118
wrong technique in product usage processSignal953.73.0183
dyspnoeaSignal1982.72.4222
coughSignal982.72.3107
off label useSignal2802.52.2262
product use in unapproved indication632.01.630
drug ineffective2431.41.335
incorrect dose administered411.41.04
headache450.60.415
pain380.50.421

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.